Patrick R. Trucchio
Stock Analyst at HC Wainwright & Co.
(4.85)
# 77
Out of 5,044 analysts
31
Total ratings
77.42%
Success rate
36.96%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick R. Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANRO Alto Neuroscience | Maintains: Buy | $10 → $50 | $13.62 | +267.11% | 2 | Oct 24, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $33.75 | +196.30% | 1 | Oct 22, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $4.06 | +195.57% | 2 | Oct 20, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $40 | $3.00 | +1,233.33% | 3 | Oct 16, 2025 | |
| PHVS Pharvaris | Initiates: Buy | $60 | $22.65 | +164.90% | 1 | Oct 15, 2025 | |
| ASMB Assembly Biosciences | Reiterates: Buy | $50 | $30.89 | +61.86% | 1 | Oct 14, 2025 | |
| BEAM Beam Therapeutics | Reiterates: Buy | $80 | $26.43 | +202.69% | 2 | Oct 10, 2025 | |
| ALNY Alnylam Pharmaceuticals | Reiterates: Buy | $570 | $475.91 | +19.77% | 2 | Oct 10, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Reiterates: Buy | $80 | $39.55 | +102.28% | 2 | Oct 8, 2025 | |
| QURE uniQure | Maintains: Buy | $70 → $110 | $70.00 | +57.14% | 4 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $55 | $29.64 | +85.56% | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.96 | +151.68% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $7.31 | +925.99% | 1 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $6.43 | +133.28% | 1 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.66 | +543.78% | 1 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $57.24 | +48.51% | 2 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $9.32 | +436.48% | 2 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.59 | +1,593.48% | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.12 | +135.85% | 1 | Aug 27, 2025 |
Alto Neuroscience
Oct 24, 2025
Maintains: Buy
Price Target: $10 → $50
Current: $13.62
Upside: +267.11%
Immunocore Holdings
Oct 22, 2025
Reiterates: Buy
Price Target: $100
Current: $33.75
Upside: +196.30%
Altimmune
Oct 20, 2025
Reiterates: Buy
Price Target: $12
Current: $4.06
Upside: +195.57%
NRx Pharmaceuticals
Oct 16, 2025
Reiterates: Buy
Price Target: $40
Current: $3.00
Upside: +1,233.33%
Pharvaris
Oct 15, 2025
Initiates: Buy
Price Target: $60
Current: $22.65
Upside: +164.90%
Assembly Biosciences
Oct 14, 2025
Reiterates: Buy
Price Target: $50
Current: $30.89
Upside: +61.86%
Beam Therapeutics
Oct 10, 2025
Reiterates: Buy
Price Target: $80
Current: $26.43
Upside: +202.69%
Alnylam Pharmaceuticals
Oct 10, 2025
Reiterates: Buy
Price Target: $570
Current: $475.91
Upside: +19.77%
Arrowhead Pharmaceuticals
Oct 8, 2025
Reiterates: Buy
Price Target: $80
Current: $39.55
Upside: +102.28%
uniQure
Oct 6, 2025
Maintains: Buy
Price Target: $70 → $110
Current: $70.00
Upside: +57.14%
Sep 25, 2025
Maintains: Buy
Price Target: $70 → $55
Current: $29.64
Upside: +85.56%
Sep 23, 2025
Reiterates: Buy
Price Target: $15
Current: $5.96
Upside: +151.68%
Sep 16, 2025
Reiterates: Buy
Price Target: $75
Current: $7.31
Upside: +925.99%
Sep 15, 2025
Reiterates: Buy
Price Target: $15
Current: $6.43
Upside: +133.28%
Sep 15, 2025
Reiterates: Buy
Price Target: $30
Current: $4.66
Upside: +543.78%
Sep 15, 2025
Reiterates: Buy
Price Target: $85
Current: $57.24
Upside: +48.51%
Sep 12, 2025
Reiterates: Buy
Price Target: $50
Current: $9.32
Upside: +436.48%
Sep 4, 2025
Reiterates: Buy
Price Target: $10
Current: $0.59
Upside: +1,593.48%
Aug 27, 2025
Reiterates: Buy
Price Target: $5
Current: $2.12
Upside: +135.85%